Tim Ferriss and Kevin Rose reunite over tequila for another Random Show, and this one swings from the heaviest material they have covered in years (the death of their friend Om Malik, aging parents, dementia, and what grief actually is) to Zen retreat breakthroughs, rock climbing as a post-50 obsession, a phase 3 LSD trial for anxiety, AI-powered smart homes, the coming wave of AI IPOs, and the single investing lesson both keep relearning: let your winners run, and when you love a product, buy the company.

TLDW

Kevin reframes the loss of Om Malik and his father through a simple equation: grief is love with nowhere to go, and the sorrow is proof of how lucky you were. Tim adds Tim Urban’s “The Tail End” math (you have spent roughly 95% of your lifetime hours with your parents by high school graduation) and Sam Harris’s “The Last Time” meditation. Kevin recounts a micro-awakening at a five-day silent Zen retreat (“nothing lacking”), both plug their meditation app The Way with Henry Shukman, and Tim declares multi-pitch climbing in Yosemite his next deliberate-practice obsession, complete with hangboard protocols and grip-training gear. The health segment covers A2 whey, venison organ-meat sticks as a multivitamin, the 1,3-butanediol ketone controversy, ketones temporarily unlocking speech in relatives with dementia, terminal lucidity, a JAMA phase 3 trial of MM120 (lysergide) showing 12 weeks of anxiety relief from a single dose, and the Norwegian 4×4 protocol whose hippocampal benefits may persist for five years. The AI segment runs from Kevin’s Claude-coded camera system that opens his gate via license plate recognition, to Tim’s 20-year angel investing retrospective built with Claude Code and the Gmail API, to their handicapping of Google versus Anthropic versus OpenAI, China’s open-source push, local inference boxes, and why buying at IPO and holding may match venture returns.

Thoughts

The emotional spine of this episode is the best thing in it. Kevin’s formulation, that the gap left by a death “is just love at the end of the day,” is not new philosophy, but it lands differently coming from someone actively managing a dying dog, a mother with dementia, and a friend’s fresh death, all in the same month. The practical corollary the two keep circling is time-boxing: Tim Urban’s Tail End math and Sam Harris’s “last time” framing both convert vague mortality awareness into a scheduling problem. Tim credits one short blog post with causing years of family trips that his emotionally reserved family would never have taken otherwise. That is about as strong an endorsement as content can get: it changed the calendar, not just the mood.

The health middle of the show is classic Random Show in that the interesting part is the epistemology, not the products. Tim flags that the loudest critics of 1,3-butanediol ketones sell competing ketone salts, applies a shelf-life heuristic to processed meat instead of memorizing ingredient lists, and treats organ-meat sticks as a dosed multivitamin rather than a diet. The MM120 discussion is the meatiest science: a five-arm randomized trial where a single 100 microgram dose of lysergide produced roughly twelve weeks of relief in generalized anxiety disorder, which Tim, who has been diagnosed with GAD and OCD, reads as a plausible future where anxiety treatment is episodic rather than daily. The unresolved tension they name honestly: the promising dementia signals (ketones, psilocybin case reports, microdosing) all crash into the consent problem. A person who cannot consent cannot sign up for a hallucinogen, and “it might give you half a day of real conversation back” is both a miracle and an ethical minefield.

The AI section quietly contains one of the more useful predictions frameworks going: Kevin’s argument that Google’s confusing high-bandwidth TPU architecture only makes sense as a bet on continuous learning, where models stop shipping as discrete releases and start improving around the clock like a child. If self-improving models are really 12 to 18 months out, the “model drop” news cycle this episode itself participates in (new Sonnet today, Mythos tomorrow) is a temporary artifact. Tim’s counterweight is human-scale and more sobering: an AI trained on your own writing produces in 30 seconds what takes you 30 hours, and he compares the demoralization to Lee Sedol retiring after AlphaGo. His book sales chart, stable for a decade and then compounding downward every year since ChatGPT launched, is the receipts. The tension between “AI made my 20-year retrospective possible” and “AI is draining my motivation to write” is the honest version of the AI discourse most podcasts flatten into one direction.

The investing segment is the most immediately actionable. Three ideas stack neatly: let winners run (Tim has lost more money selling early than he made buying), the venture-returns myth (a famous firm’s own analysis found that buying at IPO and holding a decade roughly matched their gains from early rounds through lockup), and buy-what-you-use (the friend who spent $100k on a top-of-the-line Tesla instead of Tesla stock forfeited roughly $15 million; teenage Tim bought Pixar after seeing Toy Story). None of this is sophisticated, which is the point both make explicitly: with Anthropic and OpenAI racing to IPO, ordinary people who use these tools daily will get a shot the private markets never gave them, and the discipline that matters is holding, not access.

Key Takeaways

• Kevin and Tim lost their friend and colleague Om Malik of True Ventures within the past week; Kevin found out mid-way through a five-day silent meditation retreat.
• Kevin’s reframe on grief: the severe sense of loss is “just love at the end of the day.” The gaping hole his father’s death left is love manifested through sorrow, and recognizing that converts anguish into gratitude for having crossed paths at all.
• Tim credits Matt Mullenweg twice: for organizing the Antarctica trip where he got days of uninterrupted time with Om (including a visit to an emperor penguin colony), and for sending him Tim Urban’s blog post “The Tail End.”
• The Tail End’s core math: by high school graduation you have used up roughly 90 to 95% of the total in-person hours you will ever spend with your parents. Reading it drove Tim to organize regular family trips, awkwardness be damned, before his father’s mobility declined.
• Sam Harris’s short meditation “The Last Time” pairs with it: for many activities you will do a last time without knowing it was the last time.
• Kevin’s 15-year-old dog Toaster had a violent shaking episode (a stress syndrome after standing six hours at a vet visit, not a terminal event), and Kevin’s takeaway from being covered in the aftermath was that when you love an animal that much, none of it matters.
• At a traditional Zen sesshin with Henry Shukman and his visiting Japanese teacher Yamada Roshi, Kevin had a two-second micro-insight while working his koan: a felt sense of “nothing lacking,” where nothing could be added or taken away because everything was already fully present. Not an emotion, a steady state.
• Both are investors in The Way, Henry Shukman’s single-path guided meditation app, which they frame as an ideological investment like their funding of the dog aging study on rapamycin. Tim’s favorite sessions: “Whole Earth is Medicine” and “This Too is Me.”
• Tim’s practical meditation pitch: you do not need a retreat; 10 minutes twice daily works, and there seems to be real alchemy in the twice-a-day rhythm. Kevin, once the guy who quit everything in two weeks, is coming up on five years of consistent practice.
• A physiology aside: Henry’s instruction to drop the jaw slightly mirrors how Tim’s mandibular snoring device works. Dropping the jaw an eighth of an inch down and forward opens the airway. The ancients found it by trial and error.
• Kevin, approaching 50, wants to stop saying “one day” about his bookmarked obsessions (Japanese woodworking, ships in bottles) and actually commit to things in the next two decades.
• Tim’s next deep dive is rock climbing: his surgically repaired right elbow finally allows it, and his stretch goal is multi-pitch climbing in Yosemite despite being, in his words, deadly terrified of heights, sweaty palms included.
• Tim’s philosophy of training: “training to not die sooner than is necessary” is not a sufficient goal. He needs a concrete deadline event, the way the Lancaster Classic structured his archery, to make deliberate practice worth it.
• What sold Tim on climbing longevity: the 60-to-almost-80-year-olds at Salt Lake City gyms climbing 5.11+ on weekday mornings, out-performing what he could imagine doing, plus women who cannot do five pull-ups climbing 5.13 and 5.14 on pure technique.
• Climbing is also social in a way archery never was: bouldering routes are literally called “problems,” and strangers trade beta. After decades of solitary repetition, Tim has hit his quota.
• Training tools discussed: Michael Eckert’s finger-strength course (the multiple-time pull-up world champion Kevin just bought into), the Nug (a pocket-size wooden grip trainer Tim travels with), and Abrahangs, Emil Abrahamsson’s protocol of moderate partial-bodyweight hangs, 10 seconds on and 50 seconds off for 10 minutes twice a day, which produces outsized forearm and finger gains.
• Tim’s fantasy recommendation: The Blade Itself, whose treatment of the randomness of death (a friend of Tim’s just died in a plane crash) doubles as a gratitude practice. The audiobooks are exceptional.
• Protein talk: Kevin likes Pioneer Pastures A2 whey (30 grams a shake, lactose removed, no investor relationship); Tim gets roughly 40% of his protein from Maui Nui wild-harvested axis deer venison and treats the liver-and-heart pepper sticks as a two-or-three-a-week multivitamin.
• On processed meat and nitrates, Tim’s heuristic is shelf life: if an ultraprocessed meat lasts three years on a shelf, raise an eyebrow. Minimally processed meat almost definitionally does not keep.
• Exogenous ketones containing 1,3-butanediol may carry liver toxicity risk, though Tim notes many people pushing that claim sell competing ketone salts. His personal policy: use them intermittently, not daily.
• The startling ketone anecdote: given to relatives with dementia, sentence length roughly 5xed within 20 minutes. Caveats: it tastes like gasoline, and 1,3-butanediol can affect balance, a serious concern when a broken hip is often the beginning of the end for older adults.
• Kevin moved his mother, who has non-Alzheimer’s (likely vascular) dementia, into a new home equipped with an AI radar orb that detects falls instantly. She cannot recall breakfast but knows who he is, which he will take all day long.
• The exercise-for-brain-health protocol Tim assembled with neuroscientist Dr. Tommy Wood: Norwegian 4×4 VO2 max intervals (4 minutes on, ~3 minutes off, 4 rounds) three times weekly for five to six months produces volumetric changes in the hippocampus that appear to last up to five years.
• The only bike Tim can tolerate for it is the Kaiser M3i indoor bike, because the handlebars raise enough to spare his lower back. Kevin’s sustainable alternative: incline treadmill walking while playing Duolingo chess until 40 minutes disappear. Tim’s version of don’t-let-perfect-be-the-enemy-of-good: a 5-minute, three-set gym session still counts.
• The JAMA study that grabbed Tim: a phase 3, five-arm randomized trial of MM120 (lysergide, essentially LSD, from the company formerly known as MindMed) for generalized anxiety disorder. Effects were dose-dependent, with 100 micrograms (a standard full trip) as the apparent minimum effective dose, and relief persisting through 12 weeks after a single treatment.
• Mid-conversation they discover the trial ran at Neuroscape at UCSF, their friend Adam Gazzaley’s lab, which Kevin helped fund. Tim, clinically diagnosed with GAD and OCD, finds 12 weeks of relief from one dose remarkable.
• Related dementia signals: a case report of an elderly Japanese woman with dementia who took a five-gram “heroic dose” of psilocybin mushrooms, slept 19 hours, and woke temporarily capable of full expositional conversation instead of monosyllables; Tim has also seen an unpublished case report of LSD microdosing producing similar verbal fluidity.
• Both note the hard ethics: hallucinogens for someone who cannot consent, the devastation of a bad trip you inflicted, versus the possibility of half a day of real connection or slowed decline.
• Terminal lucidity, the well-documented phenomenon of vegetative or unresponsive patients becoming fully lucid in their final days, leaves both baffled: if cognition is fully localized in a structurally deteriorated brain, where is the lucidity coming from? Kevin’s analogy: we assume nothing is backed up to the cloud.
• Tim’s caffeine pacing hack: Nutonic nootropic toothpicks (a gift from Chris Williamson), roughly 20 to 25 milligrams of caffeine each, a hard ceiling per toothpick that prevents his chain-refill coffee problem.
• Kevin’s AI smart home: his Ubiquiti camera system has a full API, so with Claude writing the glue code, the cameras now recognize individual people (and Toaster, who gets a dog emblem), play deterrent audio at loiterers in his alleyway, and open his gate automatically when they read his license plate. The camera costs about $200; anyone can do this now.
• Tim’s flagship AI project: a 20-year retrospective of his angel investing, built with Claude Code and the Gmail API, testing his own stories about his batting average against hard data. Doing it manually would have taken a year of full-time work by multiple people.
• The humbling adjacent stat from Kevin: friends with always-on AI wearables report that about 70% of what we confidently remember is what actually happened. Startup genesis stories are the same phenomenon, a five-minute bit polished until the teller believes it.
• Tim’s most valuable everyday AI use: holistic health cross-checking (contraindications between medications and supplements, could A explain D), hallucination-limited by fact-checking across multiple LLMs.
• Tim’s contrarian AI take: for most people the honest impact is small “because most shit isn’t worth doing in the first place.” Doing something well does not make it worth doing, and AI is skyrocketing the volume of efficiently produced BS.
• The demoralization is real, though: an AI trained on your writing produces in 30 seconds what takes 30 hours. Tim compares it to the top Go player who lost the joy of the game after AlphaGo, and his all-format book sales have compounded downward every year since ChatGPT launched (roughly -5%, then -28%, then -49%, tracking toward -67%).
• The prompt experiment both loved: with cross-conversation memory enabled, ask your model “What are three to five rewarding paths I might explore in the next five years?” Tim sent the answers to close friends who called them outstanding, including a non-book business idea Kevin urged him to build. Ask AI open-ended questions the way you would ask a close friend, not robot questions.
• Kevin is prototyping “Bond,” an app built from scanned values-card decks: swipe to surface your core values, form explicit agreements with partners and friends that both sides “shake” on, weight the damage of a broken bond, and accumulate a trust ledger. He calls the underlying idea dark information: real relational data (trust, reliability, empathy) that exists everywhere but has never been given physical form.
• Tim’s writing unlock for the blank page: dictate a rambling brain dump into Wispr Flow while walking, drop it into Claude to clean up, and uncomfortable procrastinated emails come together in minutes. Gear notes: Shokz OpenMeet bone-conduction headset (open ears for traffic, recommended by Exploding Kittens co-founder Elan Lee) and a Sennheiser lav mic plus the Ferrite app as a pocket recording studio that beats studio mics in echoey hotel rooms.
• State of AI, per both: the big three are Google, Anthropic, and OpenAI, with X/Grok never count-out-able (though Anthropic and Google buying excess Colossus capacity suggests weak Grok demand; Kevin still values Grok’s X-API grounding and uses it heavily for Digg). Meta has phenomenal assets but, Kevin thinks, not the talent to keep pace. Apple is quietly a couple of years out.
• Kevin’s Google thesis: they own the full stack (TPUs, data centers, models, Android’s install base), and their confusingly high-bandwidth chip architecture is a bet that the future is continuous learning, models improving 24/7 like a child rather than shipping as discrete releases. Consensus estimates put self-improving models 12 to 18 months out.
• Kevin’s insider color: touring Google X with Sergey Brin and Bill Maris a decade-plus ago, he saw Waymos years before the public knew. Google is sitting on roughly five years of undisclosed deck and holds back frontier models partly for cost and partly to avoid government intervention. In 12 months we will know where Google really stands.
• Counterweights: ChatGPT owns consumer mindshare and OpenAI must crack advertising, which is very hard; Anthropic is reportedly the fastest-scaling enterprise business ever but keeps taking hits from the administration; no frontier lab will remain unconstrained by government; and China is releasing open-source models on par with the frontier (“doing it the American way”), while AMD’s ~$4,000 local inference box can run massive models at home, eight months behind the frontier, which for many users is fine.
• The investing lessons: let winners run (Tim: “I’ve lost more money by selling stocks early than I’ve ever probably made buying the original stock”); a famous venture firm’s internal analysis found buying at IPO and holding roughly 10 years matched their gains from early-stage investing through post-lockup; and buy the company, not just the product. Kevin’s friend David Prager spent $100k on a maxed-out Tesla instead of Tesla stock, forgoing roughly $15 million. Tim’s first stock, at about 15 years old, was Pixar, bought because Toy Story convinced him animation was the future.
• Kevin relaunched Digg: from 20,000 weekly users to nearly 500,000 and millions of monthly page views, pulling the zeitgeist from X and other feeds with heavy AI curation rather than trying to build another social network.

Detailed Summary

Grief, the Tail End, and the Last Time

The show opens with banter about alcohol taxes and ketamine before turning serious: Toaster, Kevin’s 15-year-old dog, just had a terrifying (ultimately survivable) collapse, and the pair lost their friend Om Malik of True Ventures within the week. Kevin, who got the news at a silent retreat, offers the episode’s emotional thesis: the loss and sorrow are the shape love takes when the person is gone, and he would not trade the chaos of caring for people and animals for a calmer, emptier life. Tim thanks Matt Mullenweg for the Antarctica trip that gave him days of psychologically naked time with Om, and for sending him Tim Urban’s “The Tail End,” the post whose parents-time math pushed Tim into years of deliberate family trips before his father needed a wheelchair. Sam Harris’s meditation “The Last Time” extends the theme: you rarely know a last time is the last time. Kevin’s response is to do the thing one more time anyway, bouncy-house backflips at 49 included.

Zen, Nothing Lacking, and The Way

Kevin describes his five-day traditional Zen sesshin with Henry Shukman and Yamada Roshi: wall-gazing with eyes open, koan practice on the out-breath, and private interviews with the Roshi. His micro-insight, about two seconds long, was a non-emotional steady state of “nothing lacking,” everything fully present with nothing to add or subtract, what Zen calls the removal of the veil. Tim relays his favorite sessions from The Way (the app both back as a philosophical investment, like the rapamycin dog aging study): “This Too is Me,” which dissolves the burden of a squirrel-chasing mind by including everything experience serves up as you, and Henry’s small physical instructions, like dropping the jaw, which Tim connects to his mandibular snoring device: an eighth of an inch down and forward opens the airway. His bottom line: 10 minutes twice a day captures most of the benefit, and watching the formerly two-weeks-and-out Kevin sustain five years of practice has been deeply reassuring.

Rock Climbing as the Next Decade’s Project

Kevin, marching toward 50, wants to stop bookmarking dreams (Japanese woodworking, ships in bottles) and start doing them. Tim’s answer is rock climbing: his repaired right elbow finally allows it, and his stretch goal is multi-pitch in Yosemite despite sweating through his palms at the mere thought of heights. What converted him was the Salt Lake City gym crowd at 11 a.m.: retirees in their 60s and 70s climbing 5.11+, inverted on overhangs, evidence that this sport rewards technique and consistency over youth (women who cannot do five pull-ups climb 5.13). After archery, which he loved but found definitionally solitary, climbing’s social “beta”-trading culture is the draw. The training stack: Michael Eckert’s finger-strength course, the Nug pocket grip trainer, and Abrahangs (Emil Abrahamsson’s 10-seconds-on, 50-off, 10-minute, twice-daily hang protocol). A darker aside grounds the ambition: a friend of Tim’s just died in a plane crash, and The Blade Itself keeps teaching him that life-or-death is often dumb luck.

Protein, Ketones, and the Dementia Frontier

The supplements run: Kevin’s new favorite is Pioneer Pastures A2 whey (30 grams, lactose removed, gut-friendly); Tim, disclosure-forward as always, travels with Maui Nui venison and treats the liver-and-heart sticks as a twice-weekly multivitamin. On processed meat, Tim’s heuristic is shelf life over ingredient forensics. The exogenous ketone conversation is more fraught: 1,3-butanediol may stress the liver (though the claim’s loudest advocates sell competing ketone salts), so Tim doses intermittently. The astonishing part: given to relatives with dementia, ketones 5xed sentence length within 20 minutes, going from non-answer answers to full paragraphs, “offline to online.” Balance risks make it dicey in exactly the population that needs it. Kevin’s mother’s new care home uses an AI radar orb for instant fall detection. For prevention, Tim’s protocol from conversations with Dr. Tommy Wood: Norwegian 4×4 VO2 max intervals three times a week for five to six months, whose hippocampal volumetric changes appear to persist up to five years, done on the one bike (Kaiser M3i) that does not wreck his back. Kevin’s sustainable version: incline treadmill plus Duolingo chess.

MM120, Psilocybin Case Reports, and Terminal Lucidity

Tim walks through the JAMA-published phase 3 trial of MM120 (lysergide, effectively LSD) for generalized anxiety disorder: five arms (placebo, 25, 50, 100, 200 micrograms), dose-dependent response, with 100 micrograms reading as the minimum effective dose and relief lasting through the 12-week measurement window from a single supervised treatment. Kevin clicks through mid-show and discovers it ran at Neuroscape at UCSF, their friend Adam Gazzaley’s lab, which Kevin helped fund. For Tim, clinically diagnosed with GAD and OCD, episodic rather than daily treatment is the headline. The dementia thread continues: a case report of an elderly Japanese woman who took five grams of psilocybin mushrooms, slept 19 hours, and woke into temporary full conversation; an unpublished LSD microdosing report with similar verbal fluidity. Both wrestle with consent ethics. And then terminal lucidity, the documented phenomenon of unresponsive patients becoming fully lucid days before death, which neither can explain: as Kevin puts it, if it is all localized in a deteriorated brain, where is that coming from?

AI at Home and AI on Yourself

Kevin’s Ubiquiti camera system, glued together with Claude-written code against its API, now recognizes faces (and Toaster), scolds loiterers through a speaker, and opens his gate when it reads his license plate, all on a $200 camera. Tim’s project is introspective: a Claude Code plus Gmail API retrospective of 20 years of angel investing, checking who made which introductions, what he passed on, and whether his stories about his batting average survive contact with data (they mostly did; he missed fewer explicit opportunities than he feared). Kevin cites friends with always-on AI wearables: about 70% of what we confidently remember is accurate. Tim’s daily-driver use is health: cross-referencing medications, supplements, and symptoms across multiple LLMs. His caution: most tasks AI accelerates were not worth doing, and the volume of efficient BS is skyrocketing. His countervailing enthusiasm: the “what should I do in the next five years” prompt with cross-conversation memory produced ideas good enough to deeply inform his next chapter. Ask it questions like a close friend. Kevin’s next experiment is “Bond,” a values-and-trust app for making implicit relational agreements (what he calls dark information) explicit, trackable, and reflective. Tim’s practical writing unlock: Wispr Flow voice dumps cleaned up by Claude, especially for procrastinated uncomfortable emails, recorded on a Shokz OpenMeet bone-conduction headset.

The AI Landscape and Where the Money Goes

Recorded the day a new Anthropic Sonnet launched, with Mythos due the next day, the forecasting segment lands on a big three of Google, Anthropic, and OpenAI. Kevin’s Google case: full-stack ownership (TPUs whose high-bandwidth architecture only makes sense as a bet on continuous, 24/7 self-improving learning, expected within 12 to 18 months), Android distribution, data center expertise, billion-dollar engineer retention, and a five-year hidden deck he glimpsed touring Google X with Sergey Brin and Bill Maris before Waymo was public. Google holds frontier models back for cost and regulatory reasons; within a year we will know what they have. OpenAI owns consumer mindshare but must solve ads; Anthropic is crushing enterprise ARR while absorbing slaps from the administration; no lab escapes government constraint; China’s open-source frontier-parity models and AMD’s ~$4,000 local inference box threaten the subscription model from below. The investing translation: these companies are going public, and ordinary users will finally get access. The lessons both preach: let winners run, remember that buying at IPO and holding a decade roughly matched one famous firm’s venture returns, and buy the company behind the product you love, the lesson of Prager’s $15 million Tesla and teenage Tim’s Pixar shares. Kevin closes with Digg’s relaunch (20,000 to nearly 500,000 weekly users) and Tim with the sobering chart of his AI-era book sales, compounding downward since ChatGPT.

Notable Quotes

“I realized that that gap is just love at the end of the day because I wouldn’t have it unless I loved this man so much. I cared for this person so much. How lucky am I to have crossed paths with this person to get to know them?”

Kevin Rose, on losing Om Malik

“When I lost my dad, like that is just a gaping hole of love manifested through sorrow and sadness.”

Kevin Rose, on grief as a consequence of deep love

“I had a sense of nothing lacking. Nothing needed to be added and nothing even possibly could be added and nothing possibly could be taken away because everything at that moment was full in the way that it should be.”

Kevin Rose, describing his micro-insight at the Zen retreat

“Training to not die sooner than is necessary is not sufficient for me.”

Tim Ferriss, on why he needs concrete physical goals like multi-pitch climbing in Yosemite

“Doing something well does not make it important or worth doing in the first place.”

Tim Ferriss, on AI’s honest impact when most tasks were never worth doing

“I can still write, but what they can do in 30 seconds is what would take me 30 hours. And I’m just like, it really drains the motivation for me to put in those 30 hours.”

Tim Ferriss, on AIs trained on his own writing

“It’s not about those new models dropping. It’s about just like a child learning. Tomorrow it’ll be better than today for forever.”

Kevin Rose, on Google’s bet that continuous learning replaces the model-release cycle

“You got to let your winners run as long as possible. I’ve lost more money by selling stocks early than I’ve ever probably made buying the original stock.”

Tim Ferriss, the takeaway from his 20-year angel investing retrospective

“You find something that you love and you buy said object when you should actually buy the company.”

Kevin Rose, on the $100k Tesla that should have been $15 million of Tesla stock

Watch the full conversation between Tim Ferriss and Kevin Rose here on YouTube.

Related Reading

• The Tail End (Wait But Why) the Tim Urban post that quantifies how little time you have left with the people you love.
• The Way Henry Shukman’s single-path guided meditation app that both Ferriss and Rose back and use daily.
• Terminal lucidity (Wikipedia) background on the end-of-life phenomenon neither host can explain.
• LSD (Wikipedia) context for MM120/lysergide and the history behind the generalized anxiety disorder trial.
• The Botany of Desire by Michael Pollan, the book Tim cites on how dogs (and plants) co-domesticated us as much as we domesticated them.